Axe Capital Investments

Clear market notes built around the JSE, the rand, and what matters locally.

Axe Capital Trading News shares simple market takes on the stories moving South African shares, the rand, and a handful of major currency pairs.

What you will find here:

1. JSE shares, South African companies, and the local knock-on effects of big market news.

2. The rand, interest rates, and a small group of forex pairs, with USD/ZAR at the centre.

3. Global stories only when they can actually change how a local investor might act.

Latest market stories

Which Corporate Bond ETF Is the Better Buy: iShares’ LQD or State Street’s SPLB?

2026-10-11 23:32 • The Motley Fool Neutral Axe Cap view: Selective

The article compares two investment-grade corporate bond ETFs: iShares' LQD and State Street's SPLB. SPLB offers lower fees (0.04% vs 0.14%) and higher yields (6.0% vs 4.9%), but carries higher volatility and greater downside risk due to its long-duration focus. LQD provides broader maturity exposure, lower volatility, and better long-term returns despite higher costs. For most long-term investors, LQD is recommended as the more dependable choice, while SPLB suits those betting on falling interest rates.

Axe note: Two corporate bond ETFs offer different cost, yield, and risk profiles—here’s how to think about them from a South African perspective.

Not Nvidia. Not Broadcom. This Little-Known Chip Supplier Could Be the AI Boom's Best-Kept Secret.

2026-10-11 23:30 • The Motley Fool Positive Axe Cap view: Selective

Cerebras Systems, a lesser-known AI chipmaker, is gaining attention through its Wafer-Scale Engine technology designed for faster AI inference. The company secured a multi-year deal with OpenAI to deploy 750 megawatts of compute capacity through 2028, already powering GPT-5.6 Sol's Ultrafast mode. With its upcoming CS-4 system promising doubled performance and improved scalability, Cerebras positions itself as a competitive alternative to dominant players Nvidia and Broadcom in the AI infrastructure market.

Axe note: Cerebras Systems is quietly making strides with its unique AI chip tech and a major OpenAI partnership, challenging established giants.

Which iShares Healthcare ETF Is the Better Buy: Biotech-Focused IBB or Broad IYH?

2026-10-11 23:09 • The Motley Fool Positive Axe Cap view: Selective

The article compares two healthcare ETFs: IBB (biotech-focused) and IYH (broad healthcare). IBB has delivered stronger 1-year returns (38% vs 17.4%) but exhibits higher volatility and deeper drawdowns. IYH offers lower costs, higher dividend yield, and broader diversification, making it better for most long-term investors, while IBB suits those with conviction in biotech momentum who can tolerate volatility.

Axe note: Biotech sparks big returns, but broad healthcare offers steadier exposure for South African investors.

See all market stories →

What we follow

We keep the focus on JSE shares, the rand, and the currency moves that matter most to South African investors.

JSE and rand